ORAGENICS, INC. Research and Development Expense
ORAGENICS, INC. (OGEN) reported Research and Development Expense of $1.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- ORAGENICS, INC. research and development expense for the quarter ending 2026-06-30 was $1.18M, a 161.66% increase year-over-year.
- ORAGENICS, INC. research and development expense for the quarter ending 2026-03-31 was $645.47K, a 88.99% increase year-over-year.
- ORAGENICS, INC. research and development expense for the quarter ending 2025-12-31 was $670.54K, a 59.73% decline year-over-year.
- ORAGENICS, INC. research and development expense for the quarter ending 2025-09-30 was $930.89K, a 5.90% increase year-over-year.
- ORAGENICS, INC. research and development expense for fiscal 2025 was $2.39M, a 41.85% decline from fiscal 2024.
- ORAGENICS, INC. research and development expense for fiscal 2024 was $4.11M, a 73.44% decline from fiscal 2023.
- ORAGENICS, INC. research and development expense for fiscal 2023 was $15.49M, a 53.79% increase from fiscal 2022.
- ORAGENICS, INC. research and development expense for fiscal 2022 was $10.07M, a 4.85% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 4 month | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.18M 10-Q · filed 2026-08-13 | $1.82M 10-Q · filed 2026-08-13 | $2.49M derived: sum of 3 quarters · filed 2026-08-13 | $3.42M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $645.47K 10-Q · filed 2026-05-08 | $1.32M derived: sum of 2 quarters · filed 2026-05-08 | $2.25M derived: sum of 3 quarters · filed 2026-05-08 | $2.70M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $670.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.60M derived: sum of 2 quarters · filed 2026-03-16 | $2.05M derived: sum of 3 quarters · filed 2026-08-13 | $2.39M 10-K · filed 2026-03-16 | |||||
| 2025-09-30 | $930.89K 10-Q · filed 2025-11-07 | $1.38M derived: sum of 2 quarters · filed 2026-08-13 | $1.72M 10-Q · filed 2025-11-07 | $3.39M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $449.68K 10-Q · filed 2026-08-13 | $791.22K 10-Q · filed 2026-08-13 | $2.46M derived: sum of 3 quarters · filed 2026-08-13 | $3.34M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $341.54K 10-Q · filed 2026-05-08 | $2.01M derived: sum of 2 quarters · filed 2026-05-08 | $2.89M derived: sum of 3 quarters · filed 2026-05-08 | $3.79M derived: sum of 4 quarters · filed 2026-05-08 | |||||
| 2024-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.54M derived: sum of 2 quarters · filed 2026-03-16 | $3.45M derived: sum of 3 quarters · filed 2026-03-16 | $4.11M 10-K · filed 2026-03-16 | |||||
| 2024-09-30 | $879.04K 10-Q · filed 2025-11-07 | $1.79M derived: sum of 2 quarters · filed 2025-11-07 | $2.45M 10-Q · filed 2025-11-07 | $13.49M derived: sum of 4 quarters · filed 2025-11-07 | |||||
| 2024-06-30 | $906.78K 10-Q · filed 2025-08-08 | $1.57M 10-Q · filed 2025-08-08 | $12.61M derived: sum of 3 quarters · filed 2025-08-08 | $13.38M derived: sum of 4 quarters · filed 2025-08-08 | |||||
| 2024-03-31 | $663.41K 10-Q · filed 2025-05-09 | $11.71M derived: sum of 2 quarters · filed 2025-05-09 | $12.47M derived: sum of 3 quarters · filed 2025-05-09 | $14.48M derived: sum of 4 quarters · filed 2025-05-09 | |||||
| 2023-12-31 | $11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $11.81M derived: sum of 2 quarters · filed 2025-03-14 | $13.82M derived: sum of 3 quarters · filed 2025-03-14 | $15.49M 10-K · filed 2025-03-14 | |||||
| 2023-09-30 | $769.35K 10-Q · filed 2024-11-13 | $2.78M derived: sum of 2 quarters · filed 2024-11-13 | $4.45M 10-Q · filed 2024-11-13 | $5.86M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $2.01M 10-Q · filed 2024-08-09 | $3.68M 10-Q · filed 2024-08-09 | $5.09M derived: sum of 3 quarters · filed 2024-08-09 | $7.87M derived: sum of 4 quarters · filed 2024-08-09 | |||||
| 2023-03-31 | $1.67M 10-Q · filed 2024-05-15 | $3.08M derived: sum of 2 quarters · filed 2024-05-15 | $5.86M derived: sum of 3 quarters · filed 2024-05-15 | $8.45M derived: sum of 4 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $4.19M derived: sum of 2 quarters · filed 2024-03-29 | $6.78M derived: sum of 3 quarters · filed 2024-03-29 | $10.07M 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | $2.78M 10-Q · filed 2023-11-09 | $2.82M 10-Q · filed 2022-11-14 | $5.37M derived: sum of 2 quarters · filed 2023-11-09 | $8.66M 10-Q · filed 2023-11-09 | $10.60M 10-Q · filed 2022-11-14 | $9.97M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $2.59M 10-Q · filed 2023-08-11 | $3.03M 10-Q · filed 2022-08-09 | $2.59M 10-Q/A · filed 2023-04-14 | $5.88M 10-Q · filed 2023-08-11 | $7.77M 10-Q · filed 2022-08-09 | $7.19M derived: sum of 3 quarters · filed 2023-08-11 | $10.74M derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | $3.29M 10-Q · filed 2023-05-12 | $4.74M 10-Q · filed 2022-05-13 | $4.60M derived: sum of 2 quarters · filed 2023-05-12 | $8.15M derived: sum of 3 quarters · filed 2023-05-12 | $10.62M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.31M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | $4.86M derived: sum of 2 quarters · filed 2023-04-17 | $7.33M derived: sum of 3 quarters · filed 2023-04-17 | $10.59M 10-K · filed 2023-04-17 | |||||
| 2021-09-30 | $3.55M 10-Q/A · filed 2023-04-14 | $6.01M derived: sum of 2 quarters · filed 2023-04-14 | $9.28M 10-Q/A · filed 2023-04-14 | $12.63M derived: sum of 4 quarters · filed 2023-04-14 | |||||
| 2021-06-30 | $2.47M 10-Q/A · filed 2023-04-14 | $5.73M 10-Q/A · filed 2023-04-14 | $9.08M derived: sum of 3 quarters · filed 2023-04-14 | $12.58M derived: sum of 4 quarters · filed 2023-04-14 | |||||
| 2021-03-31 | $3.26M 10-Q/A · filed 2023-04-14 | $6.61M derived: sum of 2 quarters · filed 2023-04-14 | $10.11M derived: sum of 3 quarters · filed 2023-04-14 | $21.66M derived: sum of 4 quarters · filed 2023-04-14 | |||||
| 2020-12-31 | $3.35M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29 | $6.85M derived: sum of 2 quarters · filed 2022-07-29 | $18.39M derived: sum of 3 quarters · filed 2022-07-29 | $22.11M 10-K/A · filed 2022-07-29 | |||||
| 2020-09-30 | $3.50M 10-Q · filed 2021-11-15 | $15.04M derived: sum of 2 quarters · filed 2021-11-15 | $18.76M 10-Q · filed 2021-11-15 | $21.51M derived: sum of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | $11.54M 10-Q · filed 2021-08-16 | $15.26M 10-Q · filed 2021-08-16 | $18.02M derived: sum of 3 quarters · filed 2021-08-16 | $21.08M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2020-03-31 | $3.71M 10-Q · filed 2021-05-03 | $6.47M derived: sum of 2 quarters · filed 2021-05-03 | $9.54M derived: sum of 3 quarters · filed 2021-05-03 | $13.42M derived: sum of 4 quarters · filed 2021-05-03 | |||||
| 2019-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.83M derived: sum of 2 quarters · filed 2021-03-01 | $9.71M derived: sum of 3 quarters · filed 2021-03-01 | $12.12M 10-K · filed 2021-03-01 | |||||
| 2019-09-30 | $3.07M 10-Q · filed 2020-11-10 | $6.95M derived: sum of 2 quarters · filed 2020-11-10 | $9.36M 10-Q · filed 2020-11-10 | $11.15M derived: sum of 4 quarters · filed 2020-11-10 | |||||
| 2019-06-30 | $3.88M 10-Q · filed 2020-08-14 | $6.29M 10-Q · filed 2020-08-14 | $8.09M derived: sum of 3 quarters · filed 2020-08-14 | $9.67M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2019-03-31 | $2.41M 10-Q · filed 2020-05-15 | $4.21M derived: sum of 2 quarters · filed 2020-05-15 | $5.79M derived: sum of 3 quarters · filed 2020-05-15 | $7.06M derived: sum of 4 quarters · filed 2020-05-15 | |||||
| 2018-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $3.37M derived: sum of 2 quarters · filed 2020-03-04 | $4.65M derived: sum of 3 quarters · filed 2020-03-04 | $5.97M 10-K · filed 2020-03-04 | |||||
| 2018-09-30 | $1.58M 10-Q · filed 2019-11-14 | $2.85M derived: sum of 2 quarters · filed 2019-11-14 | $4.18M 10-Q · filed 2019-11-14 | $4.99M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $1.27M 10-Q · filed 2018-08-13 | $2.60M 10-Q · filed 2019-08-14 | $3.41M derived: sum of 3 quarters · filed 2019-08-14 | $4.41M derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $1.33M 10-Q · filed 2019-05-13 | $2.14M derived: sum of 2 quarters · filed 2019-05-13 | $3.14M derived: sum of 3 quarters · filed 2019-05-13 | $3.74M derived: sum of 4 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $815.31K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.81M derived: sum of 2 quarters · filed 2019-03-29 | $2.42M derived: sum of 3 quarters · filed 2019-03-29 | $3.54M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $996.48K 10-Q · filed 2018-11-13 | $1.60M derived: sum of 2 quarters · filed 2018-11-13 | $2.72M 10-Q · filed 2018-11-13 | $4.50M derived: sum of 4 quarters · filed 2018-11-13 | |||||
| 2017-06-30 | $605.41K 10-Q · filed 2018-08-13 | $1.73M 10-Q · filed 2018-08-13 | $3.50M derived: sum of 3 quarters · filed 2018-08-13 | $4.43M derived: sum of 4 quarters · filed 2018-08-13 | |||||
| 2017-03-31 | $1.12M 10-Q · filed 2018-05-15 | $2.90M derived: sum of 2 quarters · filed 2018-05-15 | $3.82M derived: sum of 3 quarters · filed 2018-05-15 | $4.62M derived: sum of 4 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $2.70M derived: sum of 2 quarters · filed 2018-02-16 | $3.49M derived: sum of 3 quarters · filed 2018-02-16 | $4.75M 10-K · filed 2018-02-16 | |||||
| 2016-09-30 | $924.80K 10-Q · filed 2017-10-31 | $1.72M derived: sum of 2 quarters · filed 2017-10-31 | $2.98M 10-Q · filed 2017-10-31 | $4.28M derived: sum of 4 quarters · filed 2017-10-31 | |||||
| 2016-06-30 | $792.70K 10-Q · filed 2017-08-14 | $812.57K 10-Q · filed 2016-08-15 | $2.02M 10-Q · filed 2017-08-14 | $2.05M 10-Q · filed 2016-08-15 | $3.36M derived: sum of 3 quarters · filed 2017-08-14 | $4.46M derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $1.22M 10-Q · filed 2017-05-15 | $1.24M 10-Q · filed 2016-05-16 | $2.57M derived: sum of 2 quarters · filed 2017-05-15 | $3.67M derived: sum of 3 quarters · filed 2017-05-15 | $9.28M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.44M derived: sum of 2 quarters · filed 2017-02-27 | $8.06M derived: sum of 3 quarters · filed 2017-02-27 | $8.73M 10-K · filed 2017-02-27 | $8.80M 10-K · filed 2016-03-30 | ||||
| 2015-09-30 | $1.10M 10-Q · filed 2016-11-14 | $1.17M 10-Q · filed 2015-11-06 | $6.72M derived: sum of 2 quarters · filed 2016-11-14 | $7.39M 10-Q · filed 2016-11-14 | $7.46M 10-Q · filed 2015-11-06 | $7.94M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $5.61M 10-Q · filed 2016-08-15 | $6.29M 10-Q · filed 2016-08-15 | $6.84M derived: sum of 3 quarters · filed 2016-05-16 | $7.43M derived: sum of 4 quarters · filed 2016-05-16 | |||||
| 2015-03-31 | $676.60K 10-Q · filed 2016-05-16 | $1.22M derived: sum of 2 quarters · filed 2016-05-16 | $1.82M derived: sum of 3 quarters · filed 2016-05-16 | $2.73M derived: sum of 4 quarters · filed 2016-05-16 | |||||
| 2014-12-31 | $548.23K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.15M derived: sum of 2 quarters · filed 2016-03-30 | $2.05M derived: sum of 3 quarters · filed 2016-03-30 | $3.07M 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | $597.03K 10-Q · filed 2015-11-06 | $1.50M derived: sum of 2 quarters · filed 2015-11-06 | $2.52M 10-Q · filed 2015-11-06 | $3.59M derived: sum of 4 quarters · filed 2015-11-06 | |||||
| 2014-06-30 | $903.33K 10-Q · filed 2015-08-07 | $1.92M 10-Q · filed 2015-08-07 | $2.99M derived: sum of 3 quarters · filed 2015-08-07 | $9.90M derived: sum of 4 quarters · filed 2015-08-07 | |||||
| 2014-03-31 | $1.02M 10-Q · filed 2015-05-08 | $2.09M derived: sum of 2 quarters · filed 2015-05-08 | $8.99M derived: sum of 3 quarters · filed 2015-05-08 | $9.63M derived: sum of 4 quarters · filed 2015-05-08 | |||||
| 2013-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $7.98M derived: sum of 2 quarters · filed 2015-02-27 | $8.61M derived: sum of 3 quarters · filed 2015-02-27 | $9.36M 10-K · filed 2015-02-27 | |||||
| 2013-09-30 | $6.91M 10-Q · filed 2014-11-03 | $7.54M derived: sum of 2 quarters · filed 2014-11-03 | $8.29M 10-Q · filed 2014-11-03 | $9.02M derived: sum of 4 quarters · filed 2014-11-03 | |||||
| 2013-06-30 | $636.97K 10-Q · filed 2014-08-07 | $1.38M 10-Q · filed 2014-08-07 | $2.11M derived: sum of 3 quarters · filed 2014-08-07 | $2.71M derived: sum of 4 quarters · filed 2014-08-07 | |||||
| 2013-03-31 | $745.39K 10-Q · filed 2014-05-09 | $1.48M derived: sum of 2 quarters · filed 2014-05-09 | $2.08M derived: sum of 3 quarters · filed 2014-05-09 | $8.25M derived: sum of 4 quarters · filed 2014-05-09 | |||||
| 2012-12-31 | $730.21K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.33M derived: sum of 2 quarters · filed 2014-02-28 | $7.51M derived: sum of 3 quarters · filed 2014-02-28 | $7.86M 10-K · filed 2014-02-28 | |||||
| 2012-09-30 | $600.21K 10-Q · filed 2013-10-25 | $6.78M derived: sum of 2 quarters · filed 2013-10-25 | $7.13M 10-Q · filed 2013-10-25 | $7.97M derived: sum of 4 quarters · filed 2013-10-25 | |||||
| 2012-06-30 | $6.18M 10-Q · filed 2013-08-12 | $6.53M 10-Q · filed 2013-08-12 | $7.37M derived: sum of 3 quarters · filed 2013-08-12 | $7.94M derived: sum of 4 quarters · filed 2013-08-12 | |||||
| 2012-03-31 | $353.20K 10-Q · filed 2013-05-15 | $1.20M derived: sum of 2 quarters · filed 2013-05-15 | $1.76M derived: sum of 3 quarters · filed 2013-05-15 | $2.39M derived: sum of 4 quarters · filed 2013-05-15 | |||||
| 2011-12-31 | $842.19K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $1.40M derived: sum of 2 quarters · filed 2013-03-26 | $2.04M derived: sum of 3 quarters · filed 2013-03-26 | $2.45M 10-K · filed 2013-03-26 | |||||
| 2011-09-30 | $562.72K 10-Q · filed 2012-11-14 | $1.19M derived: sum of 2 quarters · filed 2012-11-14 | $1.61M 10-Q · filed 2012-11-14 | $2.25M derived: sum of 4 quarters · filed 2012-11-14 | |||||
| 2011-06-30 | $631.36K 10-Q · filed 2012-08-10 | $1.04M 10-Q · filed 2012-08-10 | $1.69M derived: sum of 3 quarters · filed 2012-08-10 | $2.15M derived: sum of 4 quarters · filed 2012-08-10 | |||||
| 2011-03-31 | $412.90K 10-Q · filed 2012-05-15 | $1.05M derived: sum of 2 quarters · filed 2012-05-15 | $1.52M derived: sum of 3 quarters · filed 2012-05-15 | $1.98M derived: sum of 4 quarters · filed 2012-05-15 | |||||
| 2010-12-31 | $641.54K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $1.10M derived: sum of 2 quarters · filed 2012-04-16 | $1.57M derived: sum of 3 quarters · filed 2012-04-16 | $2.01M 10-K · filed 2012-04-16 | |||||
| 2010-09-30 | $463.41K 10-Q · filed 2011-11-14 | $928.88K derived: sum of 2 quarters · filed 2011-11-14 | $1.37M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | $465.47K 10-Q · filed 2011-08-05 | $909.84K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |